Loren K. Mell

Loren K. Mell

University of California, San Diego

H-index: 61

North America-United States

About Loren K. Mell

Loren K. Mell, With an exceptional h-index of 61 and a recent h-index of 47 (since 2020), a distinguished researcher at University of California, San Diego, specializes in the field of image-guided radiation therapy, competing risks.

His recent articles reflect a diverse array of research interests and contributions to the field:

SMAD4 loss predicts worse overall and distant metastasis‐free survival in patients with resected pancreatic adenocarcinoma

Transoral Surgery in HPV‐Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System

Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: secondary analysis of a phase 3 randomised trial

Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer

Computational and AI-driven 3D structural analysis of human papillomavirus (HPV) oncoproteins E5, E6, and E7 reveal significant divergence of HPV E5 between low-risk and high …

Treatment considerations for patients with locoregionally advanced head and neck cancer with a contraindication to cisplatin

Comparison of Standard vs. Relative Risk Models to Define Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer

Good Radiosensitizer Hunting

Loren K. Mell Information

University

Position

Professor of Radiation Medicine

Citations(all)

14936

Citations(since 2020)

7796

Cited By

9834

hIndex(all)

61

hIndex(since 2020)

47

i10Index(all)

149

i10Index(since 2020)

129

Email

University Profile Page

Google Scholar

Loren K. Mell Skills & Research Interests

image-guided radiation therapy

competing risks

Top articles of Loren K. Mell

Title

Journal

Author(s)

Publication Date

SMAD4 loss predicts worse overall and distant metastasis‐free survival in patients with resected pancreatic adenocarcinoma

Cancer

Emily J Anstadt

Ruben Carmona

Eva Berlin

Nikhil Yegya‐Raman

Sriram Venigalla

...

2024/2/1

Transoral Surgery in HPV‐Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System

The Laryngoscope

Farhoud Faraji

Abhishek Kumar

Rohith Voora

Shady I Soliman

Daniel Cherry

...

2024/1

Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: secondary analysis of a phase 3 randomised trial

European Urology

Loren K Mell

Stephanie L Pugh

Christopher U Jones

Tyler J Nelson

Kaveh Zakeri

...

2024/4/1

Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer

Clinical and Translational Radiation Oncology

Gabriel Raab

Yao Yu

Eric Sherman

Richard Wong

Loren K Mell

...

2024/3/1

Computational and AI-driven 3D structural analysis of human papillomavirus (HPV) oncoproteins E5, E6, and E7 reveal significant divergence of HPV E5 between low-risk and high …

Virology

Riley N Jones

Sayuri Miyauchi

Souvick Roy

Nathalie Boutros

Jyoti S Mayadev

...

2024/2/1

Treatment considerations for patients with locoregionally advanced head and neck cancer with a contraindication to cisplatin

Sangwoo S Kim

Hannah C Liu

Loren K Mell

2023/3

Comparison of Standard vs. Relative Risk Models to Define Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer

International Journal of Radiation Oncology, Biology, Physics

R Morse

TJ Nelson

HC Liu

CW Williamson

A Sacco

...

2023/10/1

Good Radiosensitizer Hunting

Loren K Mell

Stuart J Wong

2023/5/1

Problems With Interpreting Treatment Effects in Observational Competing Risks Data

JAMA Otolaryngology–Head & Neck Surgery

Loren K Mell

2023/2/1

Effectiveness of Cisplatin in P16+ Oropharyngeal Cancer According to Relative Risk for Cancer Events: Ancillary Analysis of RTOG 1016

International Journal of Radiation Oncology, Biology, Physics

HC Liu

R Morse

TJ Nelson

CW Williamson

L Vitzthum

...

2023/10/1

Outcomes from a 3-fraction high-dose-rate brachytherapy regimen for patients with cervical cancer

Brachytherapy

Casey W Williamson

Nikhil V Kotha

Jingjing Zou

Derek Brown

Daniel Scanderbeg

...

2023/5/1

Characterization of Antibody Repertoires in Patients with HPV-Related HNSCC Undergoing Definitive Radiation with Immunotherapy

International Journal of Radiation Oncology, Biology, Physics

S Kim

W Sumner

S Miyauchi

RN Jones

LK Mell

...

2023/10/1

Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy

Oral Oncology

Hannah C Liu

Casey W Williamson

Jingjing Zou

Jacob R Todd

Tyler J Nelson

...

2023/1/1

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline Q and A

JCO Oncology Practice

Emrullah Yilmaz

Nofisat Ismaila

Raetasha Dabney

Nabil F Saba

Loren K Mell

2023/4

Adjuvant Radiation in Resectable Node-Positive Merkel Cell Carcinoma in the Immunotherapy Era: Implications for Future and Ongoing Trials

Paul Riviere

Anna M Dornisch

Parag Sanghvi

Loren K Mell

2023/11/23

Optimized Atlas-Based Auto-Segmentation of Bony Structures from Whole-Body Computed Tomography

Practical Radiation Oncology

Lei Gao

Tahir I Yusufaly

Casey W Williamson

Loren K Mell

2023/9/1

Safety of nivolumab added to chemoradiation therapy platforms for intermediate and high-risk locoregionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504

International Journal of Radiation Oncology* Biology* Physics

Maura L Gillison

Robert L Ferris

Jonathan Harris

A Dimitrios Colevas

Loren K Mell

...

2023/3/15

EP075/# 462 Radiation quality and workflow in NRG GY017: anti PD-L1 (atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer

Jyoti Mayadev

Wei Deng

Dmitriy Zamarin

Heather Lankes

Hayeon Kim

...

2023/11/1

Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.

Charles A Leath

Wei Deng

Loren K Mell

Debra L Richardson

Joan L Walker

...

2023/6/1

18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from …

Journal of Nuclear Medicine

Jessica Geiger

Loren Mell

Samantha Seaward

Wade Thorstad

Jonathan Beitler

...

2023/3/1

See List of Professors in Loren K. Mell University(University of California, San Diego)